This clinical trial evaluates the use of everolimus combined with endocrine therapy in women with estrogen receptor–positive, human epidermal growth receptor 2–negative advanced breast cancer.
from Cancer via ola Kala on Inoreader http://ift.tt/2FW1UzE
via IFTTT
Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου